Cancer Research UK SPIKE-1 Trial (clinical trial to find treatment)
Have you recently tested positive for COVID-10 and are 50, or over 18 with significant risk factors? Are you experiencing a high temperature (37.8°C or higher), shortness of breath, or a continuous and persistent cough? If yes, you could be eligible for the SPIKE-1 clinical trial, aiming to help find a treatment for COVID-19.
To join, you must not have any of the following conditions: lung disease, cardiovascular disease, pregnancy, cancer or other illnesses, and lactose intolerance. The trial aims to evaluate the use of a drug called camostat, which could reduce the need for hospitalisation and improve symptoms in people with COVID-19. Camostat has been licenced in Japan & Korea for over 30 years to treat Pancreatitis.
This trial is being run by Cancer Research UK’s Centre for Drug Development and is fully funded by LifeArc.
To find out more, visit: cruk.org/spike1trial
Please note this trial is currently open in the Lothian NHS region only, thank you.